New Product Line Delivers Major Advance in Immunology Research MENLO PARK, CA – LevitasBio, Inc. (levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and...
Two Industry Veterans Join Already Strong Team MENLO Park – LevitasBio, Inc., a premier end-to-end sample processing and cellular analysis provider to the life sciences market, announced the hiring of Dominique Remy-Renou as its Senior Vice President of...
MENLO PARK, CA – LevitasBio, Inc. (levitasbio.com), a premier end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing of $35 million to advance its mission of providing powerful,...
MENLO PARK, Calif., November 19, 2021 – LevitasBio has announced the expansion of its product portfolio with the release of two new product lines that will enable researchers and laboratory personnel to better process and characterize human, animal and plant samples....
LevitasBio introduces a radical alternative for cell separation and sorting with label-free cell levitation technology Published on Biotechniques – MENLO PARK, CA – 16 June 2020 Today, LevitasBio has announced the commercial release of its flagship product –...
